These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1724365)

  • 1. [Reduction of per- and postoperative blood loss with aprotinin (Trasylol) during extracorporeal circulation].
    Deleuze P; Loisance DY; Feliz A; Hillion ML; Castanié JB; Richemond J; Cachera JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84(12):1797-802. PubMed ID: 1724365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).
    Bidstrup BP; Royston D; Sapsford RN; Taylor KM
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):364-72. PubMed ID: 2465457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages].
    Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M
    Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
    Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
    Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
    Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
    Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency.
    Bidstrup BP; Underwood SR; Sapsford RN; Streets EM
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):147-52; discussion 153. PubMed ID: 7678314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of high doses of aprotinin on intra- and postoperative blood loss in surgery with artificial circulation].
    Dement'eva II; Charnaia MA; Dzemeshkevich SL; Shabalkin BV; Iavorovskiĭ AG; Piatnitskaia GKh
    Anesteziol Reanimatol; 1995; (2):91-3. PubMed ID: 7544074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery.
    Tassani P; Augustin N; Barankay A; Braun SL; Zaccaria F; Richter JA
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):682-6. PubMed ID: 11139109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aprotinin in cardiac surgery in patients with platelet anti-aggregant treatment].
    Bertrand P; Mazzucotelli JP; Loisance D; Elsayed A; Deleuze P; Cachera JP
    Arch Mal Coeur Vaiss; 1993 Oct; 86(10):1471-4. PubMed ID: 7516648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol).
    Lu H; Soria C; Commin PL; Soria J; Piwnica A; Schumann F; Regnier O; Legrand Y; Caen JP
    Thromb Haemost; 1991 Dec; 66(6):633-7. PubMed ID: 1724577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative aprotinin: effect on blood loss and transfusion requirements in cardiac operations.
    Ciçek S; Demirkiliç U; Kuralay E; Ozal E; Tatar H
    Ann Thorac Surg; 1996 May; 61(5):1372-6. PubMed ID: 8633944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscope study.
    Mohr R; Goor DA; Lusky A; Lavee J
    Circulation; 1992 Nov; 86(5 Suppl):II405-9. PubMed ID: 1385010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.